The FDA finally held a hearing on menopause—and it was long overdue. Georgie Kovacs breaks down the powerful expert testimony, the systemic failures, and why this matters for every woman navigating midlife care.

In this grounded recap, you’ll learn:

• Why the FDA’s black box warning on vaginal estrogen may be misleading
• The difference between systemic and local hormone absorption—and why it matters
• How testosterone access for women remains limited despite clear clinical need
• What experts like Dr. James Simon, Dr. Heather Hirsch, and Dr. Rachel Rubin said that might change the game
• One big thing missing: progesterone. Should women with a uterus be taking it?

“Can we fix menopause care if doctors aren’t trained, patients are afraid, and the FDA mislabels essential treatments?” -Georgie Kovacs

Resources Mentioned:

• Watch the full FDA hearing on menopause
• Georgie’s YouTube Recap

• Resources and episodes on Perimenopause & Menopause and sign up for the Perimenopause and Menopause newsletter

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Summary

Why do so many women feel dismissed in healthcare — even when they see good doctors? The problem isn’t always the people — it’s the cultural stories we’ve told about what “matters.”

Inspired by sports journalist Kate Fagan’s TED Radio Hour insight on women’s sports, Georgie draws a powerful parallel to women’s health: when we don’t tell clear stories or define the stakes, we leave research gaps, funding gaps, and entire conditions misunderstood.

In just 10 minutes, you’ll hear:

• What Kate Fagan’s quote reveals about collective blind spots
• How endometriosis, PMDD, and IUD pain show this in action
• Why better stories are the first step to better funding, research, and care
• How this idea applies far beyond women’s health, to any overlooked issue

Listen If You…

• Have ever felt unseen in a doctor’s office
• Work in healthcare, research, or policy and want better insights
• Want to understand the link between storytelling and system change

Resources & Next Steps

• Listen to the TED Radio Hour episode with Kate Fagan
• Read the full companion article: What We Don’t See, We Don’t Solve

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Summary

Celiac disease is often dismissed as just a gluten issue — but for millions, the reality is far more complex.

In this episode, Fempower Health breaks down two new studies showing:

• Why diagnosis is still delayed — especially for women, people of color, and patients with clear symptoms.
• How an immune “scar” in the gut can cause ongoing symptoms, even with a strict gluten-free diet.
• What this means for anyone still feeling dismissed or untreated.

If you’ve struggled with gut issues, chronic symptoms, or frustrating medical visits, this is for you.

Listen now to learn

• The top risk factors that should lead to celiac testing — but often don’t
• What researchers found when they looked at individual gut cells
• How to use this knowledge to ask better questions about your health

Resources Mentioned

• Learn about Beyond Celiac — research and advocacy
• Full article: Celiac Disease Isn’t Just Gluten: Why Diagnosis Is Delayed—and Symptoms Linger

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Summary:

In this episode of the Fempower Health Podcast, we unpack one of the most important shifts happening in gynecology that few patients know about: salpingectomy—the removal of the fallopian tubes—is replacing tubal ligation in many cases as a way to reduce ovarian cancer risk.

Research has shown that most ovarian cancers actually begin in the fallopian tubes, not the ovaries. But outdated coding, confusing consent processes, and insurance issues have made this simple, evidence-based cancer prevention tool harder for women to access—or even understand.

This 10-minute episode breaks it all down in plain English.

🩺 What You’ll Learn:

• Why most ovarian cancers don’t start in the ovaries
• What salpingectomy is—and how it differs from tubal ligation
• Why more doctors are removing fallopian tubes during surgery
• How new diagnostic codes launching in Fall 2025 may improve access and insurance coverage
• What questions to ask your OB-GYN to make informed decisions

🔎 Why This Matters:

With no effective screening for ovarian cancer, prevention matters more than ever. Salpingectomy offers a promising path—but most women don’t know about it, and many have undergone surgery without fully understanding what was done.

Informed consent isn’t just a checkbox—it’s the foundation of agency in healthcare. If you or someone you love is facing a hysterectomy or sterilization procedure, this episode is a must-listen.

Resources & Links:

• Read the blog post Ovarian Cancer Might Not Start in the Ovary
• Listen to my interview with the Ovarian Cancer Research Alliance as we discuss why ovarian cancer is so hard to diagnose and why women are typically diagnosed in its later stages.
• Listen to my interview with Oriana Papin-Zoghbi about her company’s efforts to create an ovarian cancer diagnostic.

Share This Episode:

Know someone planning surgery or looking to reduce their cancer risk? Send them this episode or post it on social media. Because when women are informed, they’re empowered.

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Summary: Breast Cancer Prevention Just Took Two Big Steps Forward

In this short but powerful episode, Georgie breaks down two groundbreaking developments in breast cancer prevention that could reshape how we think about screening, menopause care, and early intervention:

1️⃣ An FDA-authorized AI tool—Clairity Breast—that predicts a woman’s five-year breast cancer risk from a standard mammogram, even when it appears normal.

2️⃣ A menopause drug, Duavee, that may help prevent invasive breast cancer in women with a history of high-risk lesions like DCIS.

These tools aren’t just high-tech—they’re practical, accessible, and represent a smarter, more equitable approach to women’s health.

Whether you're a clinician, policymaker, or woman navigating your own care, this episode breaks down what you need to know.

🔍 What You'll Learn in This Episode✅ FDA-Approved AI for Breast Cancer Risk Prediction

• What Clairity Breast is and how it works
• Why it matters for women under 50
• How it fits into current mammogram workflows
• Timeline for rollout and insurance coverage considerations

✅ Menopause Drug Duavee and Breast Cancer Prevention

• New clinical trial results shared at the ASCO 2025 meeting
• Why this treatment could benefit women with DCIS or other precancerous lesions
• What clinicians and high-risk patients should be asking now
• Duavee’s current FDA status and reimbursement landscape

✅ The Bigger Picture: Why This Is a Turning Point in Women's Health

• What these two tools signal about the future of precision and prevention
• How they're designed to work in real-world care—not just research labs
• Why this episode matters for people advocating for smarter, faster, fairer care

🎯 Who This Episode Is For

• Women navigating breast cancer risk or menopause decisions
• Clinicians, radiologists, and OB-GYNs focused on patient-centered care
• Healthcare innovators, startup leaders, and payers interested in smarter early intervention
• Policy leaders and health equity advocates

📌 Resources & References

• Read about Clairity Breast – FDA De Novo authorization details
• Learn about Duavee – Clinical trial results presented at ASCO 2025
• Check out the blog post of this episode: Breast Cancer Prevention Just Leveled Up: What Two Breakthroughs Mean for the Future of Women’s Health

📣 Help Spread the Word

If this episode helped you understand the future of breast cancer prevention, share it with a friend or clinician who needs to hear it.

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Overview

In this episode, I take a closer look at compounded medications—what they are, when they’re used, and the important nuances behind their growing popularity.

From hormone therapy and menopause care to semaglutide and GLP-1s, compounded meds are often described as personalized solutions. But these treatments exist in a regulatory gray area, with real variability in quality, safety, and effectiveness.

This episode is about cutting through confusion—without judgment or hype—and offering context to help you better understand your options.

What You’ll Learn

• What compounded medications are and when they’re used
• Why some women rely on them for hormone therapy, PCOS, progesterone intolerance, or GLP-1 access
• What’s different between FDA-approved medications and compounded versions
• Why terms like “bioidentical” can be misleading
• The impact of drug shortages, insurance limitations, and gaps in care

Why It Matters

Many people don’t realize that compounded medications aren’t FDA-approved—and that doesn’t automatically make them dangerous or ineffective. But it does mean they operate by different rules. This episode offers a grounded look at what’s happening behind the scenes and why these treatments are increasingly common in women’s health and beyond.

Resources

• Read article on Fear, misinformation, and pharmaceutical messianism in the promotion of compounded bioidentical hormone therapy
• Check out the blog post version of this episode here, which includes all citations.

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

What Every Patient and Clinician Should Know About the 2025 Guidelines for IUD Insertion Pain Management

For years, patients have reported severe pain during IUD insertions—only to be told it's "just a pinch." Now, the American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) have issued updated guidance that changes everything.

This episode breaks down what’s in the new guidelines, why it matters, and what’s still standing in the way of better care.

What We Cover in This Episode

• What ACOG and CDC now recommend for IUD pain relief
• Why misoprostol is no longer a routine option
• How reimbursement challenges affect what happens in the exam room
• What to do if your provider isn’t aware of the new guidelines
• The role of trauma-informed and shared decision-making models
• Why this shift is critical for women’s health equity and trust

Related Resources

• ACOG Clinical Consensus on Pain Management (May 2025)
• CDC U.S. SPR Update (Aug 2024)

• Resources and episodes on Pelvic Health

• Recommended Books on Hormones and Menstrual Health

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Overview:

You’ve heard of the nervous system, the endocrine system, and the immune system. But what about the endocannabinoid system (ECS)—the one that helps regulate all of them?

In this episode, Georgie breaks down one of the most overlooked systems in human biology. Discovered through cannabis research but far more than a cannabis issue, the ECS plays a critical role in maintaining balance across mood, metabolism, hormones, inflammation, pain, and immune response.

So why isn’t it taught in medical school? And how is that omission impacting the care we receive—especially for women dealing with complex, chronic symptoms?

This is a must-listen if you’re a health-conscious woman, clinician, innovator, or advocate wondering why the healthcare system keeps missing the root cause.

What You'll Learn:

• What the endocannabinoid system is—and what it isn’t
• How the ECS helps regulate key systems: hormonal, metabolic, immune, and neurological
• Why cannabis stigma is still limiting ECS education in medicine
• The real-world consequences of not teaching ECS in medical or nursing school
• Why women with complex symptoms may be falling through the cracks
• How diet, stress, and trauma can dysregulate the ECS—and what to do about it
• What clinicians, patients, and innovators need to know now

Related Resources:

• Read the blog post: The System That Regulates Everything (citations for this episode included)

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

🎧 Episode Summary:

Over 50% of women with chronic vaginal pain considered giving up on care altogether, according to a new JAMA Network Open study co-authored by Drs. Jill Krapf and Chailee Moss. In this episode, Georgie breaks down the findings, explores why this kind of dismissal is so common in women’s health, and explains how communication—not just diagnosis—can make or break care.

If you’ve ever been told “everything looks normal” when you were in pain, this episode is for you.

🔍 What's Covered:

• Why over half of women with vaginal pain say they nearly gave up on care—and what that says about the system
• How seemingly harmless phrases like “your exam is normal” can cause lasting harm
• What two leading experts are doing differently—and why their approach is worth hearing
• Why this isn’t about blaming doctors—but it is about breaking the cycle
• What every woman (and clinician) should understand about trust, trauma, and communication in healthcare

Resources:

• Resources and episodes on Pelvic Health

• Read the Experiences of Care and Gaslighting in Patients With Vulvovaginal Disorders study
• Learn about TightLipped and the National Vulvodynia Association

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**

Episode Overview

In this episode of Fempower Health, we break down one of the most common—and misunderstood—conditions women face after menopause: Genitourinary Syndrome of Menopause (GSM).

Often referred to by symptoms like vaginal dryness, painful sex, burning with urination, or frequent UTIs, GSM affects nearly half of postmenopausal women. Yet many women are never told it has a name—let alone that it’s treatable.

We’re unpacking what the new 2025 GSM guidelines reveal, and why they mark a turning point in how clinicians should diagnose and treat this condition.

What You’ll Learn

• What Genitourinary Syndrome of Menopause (GSM) really means
• How GSM symptoms impact vaginal, sexual, and urinary health
• Why vaginal estrogen is a frontline treatment, even with systemic HRT
• Common myths about lubricants, moisturizers, and “just aging”
• The difference between managing GSM vs. masking it
• Why GSM often goes unaddressed in clinical settings—and what needs to change
• What the 2025 guidelines clarify for patients and providers alike
• How untreated GSM can impact confidence, relationships, and even career performance

Why This Matters

Too often, women’s health is narrowly defined as periods, pregnancy, and menopause hot flashes. But vaginal and urinary health after menopause deserves equal attention.

Whether you're a patient, provider, or policymaker, understanding GSM is essential to changing the conversation around what midlife care really looks like.

Related Resources

• Read Burning, Dryness, Pain? These New Guidelines Change Everything
• Read the 2025 GSM Guidelines

• Resources and episodes on Perimenopause & Menopause and sign up for the Perimenopause and Menopause newsletter

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**